SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-19-014585
Filing Date
2019-08-08
Accepted
2019-08-08 16:02:26
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 1176842
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 222530
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 12182
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 12142
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 5878
12 image01.jpg GRAPHIC 42095
  Complete submission text file 0001140361-19-014585.txt   5530120

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rckt-20190630.xml EX-101.INS 863772
7 XBRL TAXONOMY EXTENSION SCHEMA rckt-20190630.xsd EX-101.SCH 45384
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20190630_cal.xml EX-101.CAL 56067
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20190630_def.xml EX-101.DEF 242452
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20190630_lab.xml EX-101.LAB 685306
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20190630_pre.xml EX-101.PRE 371607
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 191009421
SIC: 2834 Pharmaceutical Preparations